CD33 and Alzheimer disease: Along those lines, the EU-wide PHAGO project (https://www.phago.eu) funded via the Innovative Medicines Initiatives aimed to develop tools and methods to study the functioning of CD33 and related pathways in AD in order to facilitate decisions about potential drug development programs.